BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Nevada Opioid Center of Excellence (NOCE) - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://nvopioidcoe.org
X-WR-CALDESC:Events for The Nevada Opioid Center of Excellence (NOCE)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261012T060000
DTEND;TZID=America/Los_Angeles:20261012T100000
DTSTAMP:20260404T062443
CREATED:20260324T224939Z
LAST-MODIFIED:20260324T225351Z
UID:22225-1791784800-1791799200@nvopioidcoe.org
SUMMARY:Introduction to Treating Patients with Buprenorphine for Primary Care Providers
DESCRIPTION:The Overdose Prevention Engagement Network (OPEN) at the University of Michigan is a multidisciplinary team committed to improving lives and reducing harms of substance use. Through partnership with individuals\, communities\, and organizations\, OPEN provides education and resources to strengthen person-centered prevention\, treatment\, and recovery efforts.  OPEN has graciously extended a warm invitation to Indian Country providers to participate in their virtual trainings and webinar series throughout 2026 (and beyond). These sessions offer timely\, clinically relevant content that can be applied across care settings\, with CE credits available. \nDuring May 2020–April 2021\, the estimated number of drug overdose deaths in the United States exceeded 100\,000 over a 12-month period for the first time. Medications for Opioid Use Disorder (MOUD)\, like Buprenorphine\, methadone\, and naltrexone have been proven to reduce overdose and death\, and providers that hold a DEA license with Schedule III Authority can prescribe Buprenorphine. Ensuring prescribers have the knowledge to initiate MOUD is imperative to helping patients with opioid use disorder. \nLearning Objectives:\n\nUnderstand the basics of the neurobiology of addiction\nUnderstand the basic pharmacodynamics of buprenorphine\nDescribe the diagnosis\, intake\, and buprenorphine induction of a patient with OUD.\nUnderstand how to manage acute and chronic pain for patients with opioid use disorder with a specific emphasis on using buprenorphine for pain management\nDescribe key principles in the outpatient management of patients with OUD\n\nPresenters:\n\nChris Frank\, MD\, Ph.D.\nEliza Hutchinson\, MD\, FASM\n\nWho should take this training:\n\nPhysicians\nNurse Practitioners\nPhysician Assistants\n\n4 CME Credits (4.0 hours)\n\nMeets DEA Training Requirements\n\nThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN: Overdose Prevention Engagement Network. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://nvopioidcoe.org/event/introduction-to-treating-patients-with-buprenorphine-for-primary-care-providers/
LOCATION:Virtual Event
END:VEVENT
END:VCALENDAR